<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This retrospective review of hospital records analysed pregnancy outcome with 2 different treatments for women with <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriage</z:e> diagnosed with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> in the index pregnancy </plain></SENT>
<SENT sid="1" pm="."><plain>Of 64 women, 29 had received aspirin and 35 aspirin plus <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Pregnancy-induced <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0728731" disease_type="Disease or Syndrome" abbrv="">prematurity</z:e>, <z:hpo ids='HP_0001511'>intrauterine growth restriction</z:hpo> and <z:hpo ids='HP_0003811'>neonatal death</z:hpo> were considered as maternal and fetal complications </plain></SENT>
<SENT sid="3" pm="."><plain>There were no significant differences in antenatal and maternal complications between the groups </plain></SENT>
<SENT sid="4" pm="."><plain>HOwever, there were significant differences in mean anticardiolipin IgG antibody levels </plain></SENT>
<SENT sid="5" pm="."><plain>Aspirin alone or in combination with parin was equally efficacious in women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriage</z:e> </plain></SENT>
</text></document>